André Almeida1,2, Matteo Boattini3,4. 1. Department of Internal Medicine 4, Hospital de Santa Marta, Central Lisbon Hospital Centre, Rua de Santa Marta, 1169-124, Lisbon, Portugal. andre.almeida@chlc.min-saude.pt. 2. NOVA Medical School, Universidade Nova de Lisboa, Campo dos Mártires da Pátria 130, 1169-056, Lisbon, Portugal. andre.almeida@chlc.min-saude.pt. 3. Department of Internal Medicine 4, Hospital de Santa Marta, Central Lisbon Hospital Centre, Rua de Santa Marta, 1169-124, Lisbon, Portugal. 4. NOVA Medical School, Universidade Nova de Lisboa, Campo dos Mártires da Pátria 130, 1169-056, Lisbon, Portugal.
Abstract
PURPOSE OF REVIEW: Community-acquired pneumonia (CAP) is the cause of a considerable burden of morbidity and mortality among HIV-infected patients. The purpose of this study was to review recent literature for epidemiological trends and management of CAP in HIV patients. RECENT FINDINGS: While the specific infectious etiologies are very diverse, bacterial infection and tuberculosis are the main causes of CAP in this population. Bacterial CAP mostly affects high-income countries, while tuberculosis is mostly in low-/middle-income countries. Early antiretroviral therapy is of benefit for all patients regardless of etiology and immune status. Specific etiologies require individualized approaches, both therapeutically and prophylatically. Antiretroviral therapy is recommended for all patients.
PURPOSE OF REVIEW: Community-acquired pneumonia (CAP) is the cause of a considerable burden of morbidity and mortality among HIV-infectedpatients. The purpose of this study was to review recent literature for epidemiological trends and management of CAP in HIVpatients. RECENT FINDINGS: While the specific infectious etiologies are very diverse, bacterial infection and tuberculosis are the main causes of CAP in this population. Bacterial CAP mostly affects high-income countries, while tuberculosis is mostly in low-/middle-income countries. Early antiretroviral therapy is of benefit for all patients regardless of etiology and immune status. Specific etiologies require individualized approaches, both therapeutically and prophylatically. Antiretroviral therapy is recommended for all patients.
Entities:
Keywords:
Community-acquired pneumonia; Human immunodeficiency virus; Pneumonia; Tuberculosis
Authors: Filipe Froes; José Artur Paiva; Piedade Amaro; João Pedro Baptista; Gabriela Brum; Henrique Bento; Paula Duarte; Conceição Sousa Dias; Carlos Glória; Helena Estrada; Luis Telo; Eduardo Silva; João Gonçalves Pereira; Germano do Carmo Journal: Rev Port Pneumol Date: 2007 May-Jun
Authors: Jens D Lundgren; Abdel G Babiker; Fred Gordin; Sean Emery; Birgit Grund; Shweta Sharma; Anchalee Avihingsanon; David A Cooper; Gerd Fätkenheuer; Josep M Llibre; Jean-Michel Molina; Paula Munderi; Mauro Schechter; Robin Wood; Karin L Klingman; Simon Collins; H Clifford Lane; Andrew N Phillips; James D Neaton Journal: N Engl J Med Date: 2015-07-20 Impact factor: 91.245
Authors: Maricar Malinis; John Myers; Jose Bordon; Paula Peyrani; Rama Kapoor; Raul Nakamatzu; Gustavo Lopardo; Antoni Torres; Charles Feldman; M Allen; F Arnold; Julio Ramirez Journal: Int J Infect Dis Date: 2009-07-07 Impact factor: 3.623
Authors: Cheng Bo Li; Ying Zhou; Yu Wang; Sheng Liu; Wen Wang; Xu Lu; Cui Ming Sun; Pei Liu; Qing-Hai Hu; Ying Wen Journal: Front Public Health Date: 2021-11-30